These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 15634232

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 3. Low grade diffuse gliomas: shared cellular composition and morphometric differences.
    Kinjo S, Hirato J, Nakazato Y.
    Neuropathology; 2008 Oct 01; 28(5):455-65. PubMed ID: 18282166
    [Abstract] [Full Text] [Related]

  • 4. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors.
    Hirose T, Ishizawa K, Shimada S.
    Neuropathology; 2010 Dec 01; 30(6):586-96. PubMed ID: 20408960
    [Abstract] [Full Text] [Related]

  • 5. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
    Preusser M, Budka H, Rössler K, Hainfellner JA.
    Histopathology; 2007 Feb 01; 50(3):365-70. PubMed ID: 17257132
    [Abstract] [Full Text] [Related]

  • 6. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C.
    Neurol India; 2009 Feb 01; 57(5):559-66. PubMed ID: 19934553
    [Abstract] [Full Text] [Related]

  • 7. A distinct pattern of Olig2-positive cellular distribution in papillary glioneuronal tumors: a manifestation of the oligodendroglial phenotype?
    Tanaka Y, Yokoo H, Komori T, Makita Y, Ishizawa T, Hirose T, Ebato M, Shibahara J, Tsukayama C, Shibuya M, Nakazato Y.
    Acta Neuropathol; 2005 Jul 01; 110(1):39-47. PubMed ID: 15906048
    [Abstract] [Full Text] [Related]

  • 8. Alpha-internexin expression in gliomas: relationship with histological type and 1p, 19q, 10p and 10q status.
    Durand K, Guillaudeau A, Pommepuy I, Mesturoux L, Chaunavel A, Gadeaud E, Porcheron M, Moreau JJ, Labrousse F.
    J Clin Pathol; 2011 Sep 01; 64(9):793-801. PubMed ID: 21653654
    [Abstract] [Full Text] [Related]

  • 9. Olig2 labeling index is correlated with histological and molecular classifications in low-grade diffuse gliomas.
    Suzuki A, Nobusawa S, Natsume A, Suzuki H, Kim YH, Yokoo H, Nagaishi M, Ikota H, Nakazawa T, Wakabayashi T, Ohgaki H, Nakazato Y.
    J Neurooncol; 2014 Nov 01; 120(2):283-91. PubMed ID: 25085214
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression of the active subunit of the cystine/glutamate antiporter xCT is associated with loss of heterozygosity of 1p in oligodendroglial tumours WHO grade II.
    Stockhammer F, von Deimling A, van Landeghem FK.
    Histopathology; 2009 Jan 01; 54(2):241-7. PubMed ID: 19207949
    [Abstract] [Full Text] [Related]

  • 11. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
    Barresi V, Buttarelli FR, Vitarelli EE, Arcella A, Antonelli M, Giangaspero F.
    Hum Pathol; 2009 Dec 01; 40(12):1738-46. PubMed ID: 19716156
    [Abstract] [Full Text] [Related]

  • 12. Diversity of glial cell components in pilocytic astrocytoma.
    Tanaka Y, Sasaki A, Ishiuchi S, Nakazato Y.
    Neuropathology; 2008 Aug 01; 28(4):399-407. PubMed ID: 18312545
    [Abstract] [Full Text] [Related]

  • 13. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
    Ligon KL, Alberta JA, Kho AT, Weiss J, Kwaan MR, Nutt CL, Louis DN, Stiles CD, Rowitch DH.
    J Neuropathol Exp Neurol; 2004 May 01; 63(5):499-509. PubMed ID: 15198128
    [Abstract] [Full Text] [Related]

  • 14. OLIG2 as a specific marker of oligodendroglial tumour cells.
    Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M, Delattre JY, Poirier J, Zalc B, Hoang-Xuan K.
    Lancet; 2001 Jul 28; 358(9278):298-300. PubMed ID: 11498220
    [Abstract] [Full Text] [Related]

  • 15. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
    Marko NF, Prayson RA, Barnett GH, Weil RJ.
    Genomics; 2010 Jan 28; 95(1):16-24. PubMed ID: 19835948
    [Abstract] [Full Text] [Related]

  • 16. [Histological and molecular classification of gliomas].
    Figarella-Branger D, Colin C, Coulibaly B, Quilichini B, Maues De Paula A, Fernandez C, Bouvier C.
    Rev Neurol (Paris); 2008 Jan 28; 164(6-7):505-15. PubMed ID: 18565348
    [Abstract] [Full Text] [Related]

  • 17. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
    Reyaz N, Tayyab M, Khan SA, Siddique T.
    J Coll Physicians Surg Pak; 2005 Aug 28; 15(8):472-5. PubMed ID: 16202357
    [Abstract] [Full Text] [Related]

  • 18. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.
    Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H, Nistér M, Smits A, Ren ZP.
    Acta Neuropathol; 2007 Feb 28; 113(2):129-36. PubMed ID: 17031656
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.
    Aguirre-Cruz L, Mokhtari K, Hoang-Xuan K, Marie Y, Criniere E, Taillibert S, Lopes M, Delattre JY, Sanson M.
    J Neurooncol; 2004 May 28; 67(3):265-71. PubMed ID: 15164981
    [Abstract] [Full Text] [Related]

  • 20. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
    Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2004 Jul 28; 108(1):49-56. PubMed ID: 15118874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.